American Cutaneous Leishmaniasis in French Guiana: A Retrospective Comparison Between Liposomal Amphotericin B and Meglumine Antimoniate

British Journal of Dermatology - United Kingdom
doi 10.1111/bjd.18964
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Imiquimod in Combination With Meglumine Antimoniate for Cutaneous Leishmaniasis

Archives of Dermatology
2006English

Intralesional Meglumine Antimoniate for the Treatment of Localised Cutaneous Leishmaniasis: A Retrospective Review of a Brazilian Referral Centre

Memorias do Instituto Oswaldo Cruz
MedicineMicrobiology
2016English

Intralesional Infiltration Versus Parenteral Use of Meglumine Antimoniate for Treatment of Cutaneous Leishmaniasis: A Cost-Effectiveness Analysis

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2019English

Meglumine Antimoniate Intralesional Infiltration for Localised Cutaneous Leishmaniasis: A Single Arm, Open Label, Phase II Clinical Trial

Memorias do Instituto Oswaldo Cruz
MedicineMicrobiology
2018English

Alterations in Evoked Otoacoustic Emissions by the Use of Meglumine Antimoniate in American Tegumentary Leishmaniasis Patients

PLoS ONE
Multidisciplinary
2017English

Liposomal Amphotericin B

Medical mycology journal
Infectious DiseasesMicrobiology
2005English

Low Dose Liposomal Amphotericin B Seems to Be Effective Against Visceral Leishmaniasis

BMJ
2001English

Efficacy of Meglumine Antimoniate Under Low Polymerization State Orally Administrated in Murine Model of Visceral Leishmaniasis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

RecurrentCandida albicansVentriculitis Treated With Intraventricular Liposomal Amphotericin B

Case Reports in Infectious Diseases
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy